Go Pro
→ Buy These Stocks Before August 31st (From TradeSmith) (Ad)tc pixel Free IBRN Stock Alerts

iShares Neuroscience and Healthcare ETF (IBRN) Chart & Stock Price History

iShares Neuroscience and Healthcare ETF logo
$39.14 +0.04 (+0.10%)
As of 04:10 PM Eastern
Compare

iShares Neuroscience and Healthcare ETF Stock Price Performance

The iShares Neuroscience and Healthcare ETF (IBRN) fund chart highlights key performance trends across multiple timeframes. Over the last 12 months, the fund's price has increased 61.27%, with a year-to-date return of 21.10%. In the past month, the fund has increased 3.60%, reflecting recent market activity.

As of the latest close, iShares Neuroscience and Healthcare ETF traded at $39.14 with a market cap of $5.87 million and volume of 1,751 shares.

Receive IBRN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for iShares Neuroscience and Healthcare ETF and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
5 Day
Performance
+0.72%
1 Month
Performance
+3.60%
3 Month
Performance
+9.42%
Year-To-Date
Performance
+21.10%
1 Year
Performance
+61.27%

IBRN Stock Chart for Friday, August, 14, 2026

IBRN Chart by TradingView

iShares Neuroscience and Healthcare ETF Stock Price History

Export
DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization
08/14/2026$39.10$39.14
+0.10%		$43.01$39.081,751 shs$5.87 million
08/13/2026$39.57$39.10
-1.19%		$39.10$39.10454 shs$5.87 million
08/12/2026$39.25$39.57
+0.82%		$39.60$39.062,182 shs$5.94 million
08/11/2026$39.18$39.25
+0.18%		$39.48$39.121,192 shs$5.89 million
08/10/2026$38.86$39.18
+0.82%		$39.48$38.902,024 shs$5.88 million
08/07/2026$38.57$38.86
+0.75%		$39.20$38.433,757 shs$5.83 million
08/06/2026$38.02$38.57
+1.45%		$38.89$38.3311,812 shs$5.79 million
08/05/2026$37.68$38.02
+0.90%		$38.39$37.766,827 shs$5.70 million
08/04/2026$36.70$37.68
+2.67%		$37.68$37.102,350 shs$5.65 million
08/03/2026$36.60$36.70
+0.27%		$36.76$36.0512,738 shs$5.51 million
07/31/2026$37.83$36.60
-3.25%		$36.74$36.602,838 shs$5.49 million
07/30/2026$37.00$37.83
+2.24%		$37.91$37.251,412 shs$5.67 million
07/29/2026$37.44$37.00
-1.18%		$37.61$37.00565 shs$5.55 million
07/28/2026$37.72$37.44
-0.74%		$39.06$37.273,489 shs$5.62 million
07/27/2026$37.69$37.72
+0.08%		$38.20$37.721,660 shs$5.66 million
07/24/2026$37.77$37.69
-0.21%		$37.82$37.66718 shs$5.65 million
07/23/2026$37.55$37.77
+0.59%		$37.79$37.195,519 shs$5.67 million
07/22/2026$37.87$37.55
-0.84%		$38.02$37.552,588 shs$5.63 million
07/21/2026$37.05$37.87
+2.21%		$37.87$37.771,115 shs$5.68 million
07/20/2026$37.87$37.05
-2.17%		$37.49$37.052,427 shs$5.56 million
07/17/2026$37.37$37.87
+1.34%		$37.88$37.623,629 shs$5.68 million
07/16/2026$38.03$37.37
-1.74%		$37.37$37.37234 shs$5.61 million
07/15/2026$37.78$38.03
+0.66%		$38.40$37.434,634 shs$5.70 million
07/14/2026$38.21$37.78
-1.13%		$37.91$37.717,119 shs$5.67 million
07/13/2026$39.05$38.21
-2.15%		$38.34$38.214,534 shs$5.73 million
Related Companies

This page (NYSEARCA:IBRN) was last updated on 8/14/2026 by MarketBeat.com Staff.
From Our Partners
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
Trump’s New Currency Reset
Trump is launching a new $250 bill - but that may be a distraction. Behind the scenes, Executive Order 14241 i...
Porter & Company | Sponsoredtc pixel
Buy These Stocks Before August 31st
Keith Kaplan has invested $17 million into his own AI research platform, now used by 180,000 investors worldwi...
TradeSmith | Sponsoredtc pixel
Ray Dalio: Buy Gold. Get Paid.
Ray Dalio, founder of Bridgewater Associates, is urging investors to hold 15% of their portfolio in gold and c...
Investors Alley | Sponsoredtc pixel
Your book is inside
The "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...
Profits Run | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
Gold buyout deals have handed shareholders overnight gains up to 79 percent
Gold major acquisitions have repriced junior miners overnight, with past deals delivering gains from 40% to 1,...
Golden Portfolio | Sponsoredtc pixel
Who Really Gets Rich from IPOs?
Peter Thiel turned a $500,000 stake in Meta into nearly $1 billion by investing eight years before its IPO. Tr...
Weiss Ratings | Sponsoredtc pixel